* * * 20702 adult hypertensive patients in China were included, who had no history of stroke and myocardial infarction. according to
After stratification, MTHFR C677T genotype was randomly and double-blind divided into two groups, which were given daily single-chip fixation.
Compound preparation enalapril folic acid tablets or enalapril alone, during hypertension.
Patients with blood pressure should be combined with other antihypertensive drugs according to the hypertension guidelines. Studies have shown that enalapril
Compared with the simple antihypertensive treatment, the antihypertensive treatment mainly with folic acid tablets is further significantly reduced.
The risk of first stroke is 2 1%.
JAMA Editor's Comment: Precision design is better than the rest!
Conclusion: CSPPT is a clinical study independently designed and implemented by Chinese experts, and it is a patient with hypertension in China.
Prevention of stroke provides more direct and accurate clinical evidence.